Similar articles

• Temperature-dependent substrate inhibition of the cysteine proteinase (GP57/51) from Trypanosoma cruzi.

  Lima AP, Scharfstein J, Storer AC, Ménard R. Lima AP, et al. Mol Biochem Parasitol. 1992 Dec;56(2):335-8. doi: 10.1016/0166-6851(92)90183-k. Mol Biochem Parasitol. 1992. PMID: 1484555 No abstract available.
• Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro.

  Meirelles MN, Juliano L, Carmona E, Silva SG, Costa EM, Murta AC, Scharfstein J. Meirelles MN, et al. Mol Biochem Parasitol. 1992 Jun;52(2):175-84. doi: 10.1016/0166-6851(92)90050-t. Mol Biochem Parasitol. 1992. PMID: 1620157
• Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents.

  Caputto ME, Fabian LE, Benítez D, Merlino A, Ríos N, Cerecetto H, Moltrasio GY, Moglioni AG, González M, Finkielsztein LM. Caputto ME, et al. Bioorg Med Chem. 2011 Nov 15;19(22):6818-26. doi: 10.1016/j.bmc.2011.09.037. Epub 2011 Sep 24. Bioorg Med Chem. 2011. PMID: 22000947
• Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review.

  Duschak VG, Couto AS. Duschak VG, et al. Curr Med Chem. 2009;16(24):3174-202. doi: 10.2174/092986709788802971. Curr Med Chem. 2009. PMID: 19689291 Review.
• Role of chagasin-like inhibitors as endogenous regulators of cysteine proteases in parasitic protozoa.

  Santos CC, Scharfstein J, Lima AP. Santos CC, et al. Parasitol Res. 2006 Sep;99(4):323-4. doi: 10.1007/s00436-006-0195-y. Epub 2006 Apr 25. Parasitol Res. 2006. PMID: 16636845 Review. No abstract available.